Concepedia

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate Monohydrate

Naseem A. Charoo, Daud Baraka Abdallah, Ahmed Abdalla Bakheit, Kashif Ul Haque, Hassan Ali Hassan, Bertil Abrahamsson, Rodrigo Cristofoletti, Peter Langguth, Alan Parr, James E. Polli,

Journal of Pharmaceutical Sciences · 2021 · 14 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

, , +15

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone

B Charbonnel, Avraham Karasik, Ji Liu et al. · Diabetes Care · 2006 · 790 citations · Full text

, , +17

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

Gary Herman, C. Melinda Stevens, Koen Vandyck et al. · Clinical Pharmacology & Therapeutics · 2005 · 519 citations

, , +14

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Gary Herman, Arthur Bergman, Catherine Stevens et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 499 citations

, , +17

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

Arthur Bergman, Catherine Stevens, Yanyan Zhou et al. · Clinical Therapeutics · 2006 · 266 citations

, , +10